Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.

Show other versions (1)

First-generation, E1/E3-deleted adenoviral vectors with diverse transgenes are produced routinely in laboratories worldwide for development of novel prophylactics and therapies for a variety of applications, including candidate vaccines against important infectious diseases, such as HIV/AIDS, tuberc...

Full description

Bibliographic Details
Main Authors:	Cottingham, MG, Carroll, F, Morris, S, Turner, A, Vaughan, A, Kapulu, M, Colloca, S, Siani, L, Gilbert, S, Hill, A
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
by: Cottingham, MG, et al.
Published: (2011)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
by: Biswas, S, et al.
Published: (2011)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
by: Dicks, M, et al.
Published: (2011)

Uncovering the mechanisms of adenovirus vector immunogenicity
by: Dicks, M, et al.
Published: (2013)

Simultaneous Insertion of Two Expression Cassettes into Adenovirus Vectors
by: Xavier Danthinne
Published: (2001-03-01)

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
by: Dicks, M, et al.
Published: (2015)

Generation of Cell Lines to Complement Adenovirus Vectors using Recombination-Mediated Cassette Exchange
by: Farley Daniel C, et al.
Published: (2010-12-01)

Delivery of large transgene cassettes by foamy virus vector
by: Nathan Paul Sweeney, et al.
Published: (2017-08-01)

Simian adenoviruses as vaccine vectors
by: Morris, S, et al.
Published: (2016)

Simian adenoviruses as vaccine vectors
by: Morris, S, et al.
Published: (2016)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
by: Dicks, M, et al.
Published: (2012)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
by: Sumi Biswas, et al.
Published: (2011-01-01)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
by: Warimwe, G, et al.
Published: (2013)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
by: Dicks, M, et al.
Published: (2015)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
by: Matthew D J Dicks, et al.
Published: (2012-01-01)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
by: Reyes-Sandoval, A, et al.
Published: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
by: Reyes-Sandoval, A, et al.
Published: (2012)

Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.
by: Draper, S, et al.
Published: (2013)

Dual gene expression cassette is superior than single gene cassette for enhancing sheath blight tolerance in transgenic rice
by: Subhasis Karmakar, et al.
Published: (2017-08-01)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
by: O'Hara, G, et al.
Published: (2012)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
by: Green, C, et al.
Published: (2015)

Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.
by: Orubu, T, et al.
Published: (2012)

Cytokine Responses to Adenovirus and Adenovirus Vectors
by: Svetlana Atasheva, et al.
Published: (2022-04-01)

Targeting Catecholaminergic Systems in Transgenic Rats With a CAV-2 Vector Harboring a Cre-Dependent DREADD Cassette
by: Juan-Carlos Cerpa, et al.
Published: (2020-07-01)

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.
by: Dudareva, M, et al.
Published: (2009)

Modification of antigen impacts on memory quality after adenovirus vaccination.
by: Colston, J, et al.
Published: (2016)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
by: Kapulu, M, et al.
Published: (2010)

Gene Rearrangement and Modification of Immunity Factors Are Correlated with the Insertion of Bacteriocin Cassettes in Streptococcus mutans
by: Mi Nguyen-Tra Le, et al.
Published: (2022-06-01)

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.
by: Reyes-Sandoval, A, et al.
Published: (2010)

Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors.
by: Carlisle, R, et al.
Published: (2001)

Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors
by: Carlisle, RC, et al.
Published: (2016)

Targeted Transgene Expression in Cholinergic Interneurons in the Monkey Striatum Using Canine Adenovirus Serotype 2 Vectors
by: Anne-Caroline Martel, et al.
Published: (2020-05-01)

Viral vectors as vaccine platforms: Deployment in sight
by: Rollier, C, et al.
Published: (2011)

Viral vectors as vaccine platforms: deployment in sight.
by: Rollier, C, et al.
Published: (2011)

Erratum: Prime-boost immunization with adenoviral and modified vaccinia virus ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses
by: Reyes-Sandoval, A, et al.
Published: (2011)

Evaluation of adenovirus capsid labeling versus transgene expression
by: Curiel David T, et al.
Published: (2010-01-01)

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.
by: Spencer, A, et al.
Published: (2014)

Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses
by: Sonia Marquez-Martinez, et al.
Published: (2024-01-01)

Novel expression cassettes for increasing apolipoprotein AI transgene expression in vascular endothelial cells
by: Meena Sethuraman, et al.
Published: (2022-12-01)

Construction of recombinant adenovirus-5 vector to prevent replication-competent adenovirus occurrence
by: Wenbo Xie, et al.
Published: (2023-12-01)